protein-protein interactions
inhibitors of protein
Peptide-derived bioavailable macrocycles
cyclic peptide
development of inhibitors
RNA interactions
Peptide macrocyclization
PRI inhibitors
design of bioavailable peptide-derived macrocyclic compounds
corresponding inhibitors
bioavailable macrocyclic compound
development of macrocyclic PPI
design of bioactive macrocycles
initial design principles
structured peptide binding epitopes
RNA complexes
use
elucidation of general principles
numerous novel biological targets
therapeutic agents
subsequent drug discovery campaigns
crucial biological processes
classic small molecule modulation
irregular bioactive secondary structure
starting point
stabilization
access
proposal
two-step process high target affinity
bioavailability
objective
problem of decreasing success rates
well-characterized model system
fact
potential
PPIs
decade
PRIs
Evolution
Approaches